Igyxos Biotherapeutics
PrivateLast Round
Grant
Oct 2, 2025
Total Funding Raised
$20.58M
Company Overview
Igyxos Biotherapeutics is a biotechnology company that develops monoclonal antibody-based therapeutics to treat infertility in men and women.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Igyxos Biotherapeutics Comparables
Compare Igyxos Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oxolife | 78% | |
| Granata Bio | 76% | |
| Merck | 73% | |
Igyxos Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 2, 2025 | ||||
| VC Round | Nov 14, 2023 | ||||
| Debt | Nov 14, 2023 | ||||
| Series A | Mar 21, 2019 |
Key People
Founding team and executive leadership
Igyxos Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Social Impact Enterprises | VC Round |
| Sofimac Innovation | Series A |
| GO Capital | VC Round, Series A |
| Sofimac Investment Managers | VC Round |
| Bpifrance | Debt, VC Round, Grant, Series A |
| UI Investissement | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Monthly visitors grew 1871% MoM, reaching 2.5K.
- Nov 14, 2023
$12.3M raised from Sofimac, UI Investissement, GO Capital, Bpifrance, and Social Impact Enterprises.
Igyxos Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Igyxos Biotherapeutics's valuation, stock price, and market status.